42 results
8-K
EX-99.1
INSM
Insmed Incorporated
8 Aug 24
Insmed Reports Second-Quarter 2024 Financial Results and Provides Business Update
7:00am
pregnant while taking ARIKAYCE should be apprised of the potential hazard to the fetus.
Contraindications: ARIKAYCE is contraindicated in patients
8-K
EX-99.2
INSM
Insmed Incorporated
3 Jul 24
Regulation FD Disclosure
9:00am
Brensocatib 25 mgn=575 Placebon=563 Median time, weeks (95% CI) 49.0 (40.0–NE) 50.7 (37.6–NE) 36.7 (31.1–41.4) Hazard ratio vs placebo (95% CI) 0.813 (0.695
8-K
EX-99.1
INSM
Insmed Incorporated
9 May 24
Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update
7:05am
during pregnancy, or become pregnant while taking ARIKAYCE should be apprised of the potential hazard to the fetus.
Contraindications: ARIKAYCE
8-K
EX-99.1
INSM
Insmed Incorporated
22 Feb 24
Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update
7:58am
hazard to the fetus.
Contraindications: ARIKAYCE is contraindicated in patients with known hypersensitivity to any aminoglycoside.
Most Common
8-K
EX-99.1
INSM
Insmed Incorporated
5 Jan 24
Insmed Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference
8:18am
while taking ARIKAYCE should be apprised of the potential hazard to the fetus.
Contraindications: ARIKAYCE is contraindicated in patients with known
8-K
EX-99.1
5ldg53l
26 Oct 23
Insmed Reports Third-Quarter 2023 Financial Results and Provides Business Update
7:38am
8-K
EX-99.1
rcdz7w7
5 Sep 23
Regulation FD Disclosure
7:00am
8-K
EX-99.1
a9pfuxv
3 Aug 23
Insmed Reports Second-Quarter 2023 Financial Results and Provides Business Update
7:30am
8-K
EX-99.1
ed4i ttbj4
4 May 23
Insmed Reports First Quarter 2023 Financial Results and Provides Business Update
7:30am
8-K
EX-99.1
b5y8k1fh3s m05glam
27 Oct 22
Insmed Reports Third Quarter 2022 Financial Results and Provides Business Update
7:30am
8-K
EX-99.1
pc7tyh8 dxrgdh3752
4 Aug 22
Insmed Reports Second Quarter 2022 Financial Results and Provides Business Update
7:30am
8-K
EX-99.1
p0ysfr4 is9
5 May 22
Insmed Reports First Quarter 2022 Financial Results and Provides Business Update
7:38am
8-K
EX-99.1
bmn93vptzj
17 Feb 22
Insmed Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business and Pipeline Update
7:01am
8-K
EX-99.1
3sy94w8x bu
10 Jan 22
Regulation FD Disclosure
8:30am
8-K
EX-99.1
vs6emsk
28 Oct 21
Insmed Reports Third Quarter 2021 Financial Results and Provides Business Update
7:30am
8-K
EX-99.1
gazwvt71dkkiuja6xky
5 Aug 21
Insmed Reports Second Quarter 2021 Financial Results and Provides Business Update
7:30am
8-K
EX-99.1
yki9pprdf m8fvw
6 May 21
Insmed Reports First Quarter 2021 Financial Results and Provides Business Update
7:30am
8-K
EX-99.1
77z4ecckarej eb
25 Feb 21
Insmed Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
8:29am
8-K
EX-99.1
onp03o164 9ym1p1bl
11 Jan 21
Regulation FD Disclosure
6:31am